Sirio Pharma Co., Ltd. Share Price

Equities

300791

CNE100003NB0

Food Processing

End-of-day quote Shenzhen S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
37.55 CNY -0.13% Intraday chart for Sirio Pharma Co., Ltd. +3.16% +8.34%

Financials

Sales 2024 * 4.36B 602M 50.16B Sales 2025 * 5.03B 694M 57.84B Capitalization 6.77B 934M 77.89B
Net income 2024 * 399M 55.07M 4.59B Net income 2025 * 488M 67.35M 5.62B EV / Sales 2024 * 1.55 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.35 x
P/E ratio 2024 *
17.1 x
P/E ratio 2025 *
14 x
Employees 2,610
Yield 2024 *
4.18%
Yield 2025 *
4.87%
Free-Float 27.25%
More Fundamentals * Assessed data
Dynamic Chart
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023. CI
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million. CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023. CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index CI
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares. CI
Sirio Pharma Co., Ltd. authorizes a Buyback Plan. CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023 CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022 CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index CI
More news
1 day-0.13%
1 week+3.16%
Current month+3.67%
1 month+3.16%
3 months+22.79%
6 months+17.56%
Current year+8.34%
More quotes
1 week
37.00
Extreme 37
39.60
1 month
34.20
Extreme 34.2
39.69
Current year
25.11
Extreme 25.11
39.69
1 year
24.24
Extreme 24.24
39.69
3 years
21.33
Extreme 21.33
69.50
5 years
20.36
Extreme 20.36
83.08
10 years
20.36
Extreme 20.36
83.08
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 01/15/01
Director of Finance/CFO 41 16/23/16
Director/Board Member 54 01/15/01
Members of the board TitleAgeSince
Director/Board Member 55 07/21/07
Director/Board Member 60 07/21/07
Chief Executive Officer 59 01/15/01
More insiders
Date Price Change Volume
26/24/26 37.55 -0.13% 1,508,925
25/24/25 37.6 -1.96% 1,505,800
24/24/24 38.35 -1.84% 1,849,450
23/24/23 39.07 +4.21% 2,126,550
22/24/22 37.49 +2.99% 3,661,674

End-of-day quote Shenzhen S.E., April 26, 2024

More quotes
Sirio Pharma Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company's own brand is WEWOW nutritional health food. The Company distributes its products both in the domestic market and to overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
37.55 CNY
Average target price
41.67 CNY
Spread / Average Target
+10.96%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300791 Stock